ALK-B.CO
Price:
$181
Market Cap:
$39.52B
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. It product portfolio include GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDACURE, and ITULAZAX for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food. It also provides consumer healthcare solution, which include Digital eco-system, a platform which connect and engages with allergy sufferers much earlier in the disease journey through tools and e-commerc...[Read more]
Industry
Biotechnology
IPO Date
2000-03-10
Stock Exchange
CPH
Ticker
ALK-B.CO
According to ALK-Abelló A/S’s latest financial reports and current stock price. The company's current ROE is 15.00%. This represents a change of 303.39% compared to the average of 3.72% of the last 4 quarters.
The mean historical ROE of ALK-Abelló A/S over the last ten years is 4.45%. The current 15.00% ROE has changed 236.94% with respect to the historical average. Over the past ten years (40 quarters), ALK-B.CO's ROE was at its highest in in the December 2015 quarter at 5.15%. The ROE was at its lowest in in the December 2017 quarter at -4.83%.
Average
4.45%
Median
6.99%
Minimum
-5.35%
Maximum
12.75%
Discovering the peaks and valleys of ALK-Abelló A/S ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 693.69%
Maximum Annual ROE = 12.75%
Minimum Annual Increase = -151.14%
Minimum Annual ROE = -5.35%
Year | ROE | Change |
---|---|---|
2023 | 10.93% | 30.10% |
2022 | 8.40% | 33.48% |
2021 | 6.29% | 693.69% |
2020 | 0.79% | -150.36% |
2019 | -1.57% | -70.56% |
2018 | -5.35% | 11.35% |
2017 | -4.80% | -151.14% |
2016 | 9.39% | -26.37% |
2015 | 12.75% | 65.88% |
2014 | 7.69% | 183.49% |
The current ROE of ALK-Abelló A/S (ALK-B.CO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
8.54%
5-year avg
4.97%
10-year avg
4.45%
ALK-Abelló A/S’s ROE is less than Ambu A/S (8.12%), less than GN Store Nord A/S (6.08%), less than FLSmidth & Co. A/S (6.05%), less than NKT A/S (17.33%), less than Genmab A/S (17.44%),
Company | ROE | Market cap |
---|---|---|
8.12% | $36.02B | |
6.08% | $23.31B | |
6.05% | $19.51B | |
17.33% | $35.83B | |
17.44% | $110.72B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ALK-Abelló A/S using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ALK-Abelló A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is ALK-Abelló A/S's ROE?
How is the ROE calculated for ALK-Abelló A/S (ALK-B.CO)?
What is the highest ROE for ALK-Abelló A/S (ALK-B.CO)?
What is the 3-year average ROE for ALK-Abelló A/S (ALK-B.CO)?
What is the 5-year average ROE for ALK-Abelló A/S (ALK-B.CO)?
How does the current ROE for ALK-Abelló A/S (ALK-B.CO) compare to its historical average?